Renal angiotensin-converting enzyme and blood pressure control

Kenneth E. Bernstein(Cedars-Sinai Medical Center), Romer A. González-Villalobos(Cedars-Sinai Medical Center), Jorge F. Giani(Cedars-Sinai Medical Center), Xiao Z. Shen(Cedars-Sinai Medical Center)
Current Opinion in Nephrology & Hypertension
December 30, 2013
10.1097/01.mnh.0000441047.13912.56
Cited by 55

Related Papers

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
|Nature|1991|1.3k
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
|Nature|1995|745
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility.
|PubMed|1996|440